Recombinant Human Fibulin 5 Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 9006-FB
HEK293-derived
Key Product Details
Product Specifications
Source
Human embryonic kidney cell, HEK293-derived human Fibulin 5/DANCE protein
Gln24-Phe448, with an N-terminal HA tag
Gln24-Phe448, with an N-terminal HA tag
Purity
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Tyr
Predicted Molecular Mass
49 kDa
SDS-PAGE
60-72 kDa, reducing conditions
Activity
Measured by the ability of the immobilized protein to enhance the adhesion of HUVEC human umbilical vein endothelial cells.
The ED50 for this effect is 15-90 ng/mL.
The ED50 for this effect is 15-90 ng/mL.
Formulation, Preparation and Storage
9006-FB
Formulation | Lyophilized from a 0.2 μm filtered solution in MOPS, NaCl, EDTA and CHAPS with Trehalose. |
Reconstitution |
Reconstitute at 500 μg/mL in water.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Fibulin 5/DANCE
LTBP-4, and the crosslinking lysyl oxidase-like enzymes LOXL1,2, and 4 along Fibrillin microfibrils (6, 9-12). In aged mice with decreased tissue elasticity, proteolytic removal of the N-terminal EGF-like domain prevents Fibulin 5 from interacting with Fibrillin-1 microfibrils (10). Fibulin 5 functions as an angiogenesis inhibitor by inhibiting vascular smooth muscle proliferation and migration and by limiting vascular sprouting (5, 13). Depending on the context, Fibulin 5 can function either as a tumor suppressor or enhancer of tumor cell invasiveness (14, 16). Defects in Fibulin 5 expression or function can result in a loss of connective tissue integrity, cardiac elasticity, and ability to remodel the vasculature after injury (8, 5, 15).
References
- Papke, C.L. and H. Yanagisawa (2014) Matrix Biol. 37:142.
- Nakamura, T. et al. (1999) J. Biol. Chem. 274:22476.
- Kowal, R.C. et al. (1999) Circ. Res. 84:1166.
- Kuang, P.-P. et al. (2003) Am. J. Physiol. Lung Cell. Mol. Physiol. 285:L1147.
- Spencer, J.A. et al. (2005) Proc. Natl. Acad. Sci. USA 102:2946.
- Nakamura, T. et al. (2002) Nature 415:171.
- Lomas, A.C. et al. (2007) Biochem. J. 405:417.
- Yanagisawa, H. et al. (2002) Nature 415:168.
- Wachi, H. et al. (2008) J. Biochem. 143:633.
- Hirai, M. et al. (2007) J. Cell Biol. 176:1061.
- Hirai, M. et al. (2007) EMBO J. 26:3283.
- Noda, K. et al. (2013) Proc. Natl. Acad. Sci. USA 110:2852.
- Sullivan, K.M. et al. (2007) Lab. Invest. 87:818.
- Lee, Y.-H. et al. (2008) Carcinogenesis 29:2243.
- Loeys, B. et al. (2002) Hum. Mol. Genet. 11:2113.
- Yue, W. et al. (2009) Cancer Res. 69:6339.
Alternate Names
DANCE, EVEC, FBLN5, UP50
Entrez Gene IDs
10516 (Human)
Gene Symbol
FBLN5
UniProt
Additional Fibulin 5/DANCE Products
Product Documents for Recombinant Human Fibulin 5 Protein, CF
Product Specific Notices for Recombinant Human Fibulin 5 Protein, CF
For research use only
Loading...
Loading...
Loading...